Loading...

Cost-Effectiveness of Chemoprevention with Proton Pump Inhibitors in Barrett’s Esophagus

BACKGROUND: Proton pump inhibitors (PPIs) may reduce the risk of esophageal adenocarcinoma (EAC) in patients with Barrett’s esophagus. PPIs are prescribed for virtually all patients with Barrett’s esophagus, irrespective of the presence of reflux symptoms, and represent a de facto chemopreventive ag...

Full description

Saved in:
Bibliographic Details
Published in:Dig Dis Sci
Main Authors: Sharaiha, Reem Z., Freedberg, Daniel E., Abrams, Julian A., Wang, Y. Claire
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4315516/
https://ncbi.nlm.nih.gov/pubmed/24795040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-014-3186-3
Tags: Add Tag
No Tags, Be the first to tag this record!